These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome? Peserico A, Rigon F, Semenzato G, Caretto A, Pasini CV, Betterle C. Arch Dermatol; 1981 Nov 22; 117(11):751-2. PubMed ID: 7316541 [No Abstract] [Full Text] [Related]
7. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. Naughton GK, Eisinger M, Bystryn JC. J Invest Dermatol; 1983 Dec 22; 81(6):540-2. PubMed ID: 6196421 [Abstract] [Full Text] [Related]
8. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo. Yu HS, Kao CH, Yu CL. J Invest Dermatol; 1993 Jun 22; 100(6):823-8. PubMed ID: 8496622 [Abstract] [Full Text] [Related]
9. [Autoantibodies in vitiligo. Clinical significance]. Morgan M, Castells A, Ramírez A. Med Cutan Ibero Lat Am; 1986 Jun 22; 14(2):139-42. PubMed ID: 3528710 [Abstract] [Full Text] [Related]
10. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. Norris DA, Kissinger RM, Naughton GM, Bystryn JC. J Invest Dermatol; 1988 Jun 22; 90(6):783-9. PubMed ID: 3373009 [Abstract] [Full Text] [Related]
11. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo). Merimsky O, Shoenfeld Y, Baharav E, Zigelman R, Fishman P. Hum Antibodies Hybridomas; 1996 Jun 22; 7(4):151-6. PubMed ID: 9140726 [Abstract] [Full Text] [Related]
12. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients. Park YK, Kim NS, Hann SK, Im S. J Dermatol Sci; 1996 Feb 22; 11(2):111-20. PubMed ID: 8869031 [Abstract] [Full Text] [Related]
13. Cytolytic antibodies to melanocytes in vitiligo. Cui J, Arita Y, Bystryn JC. J Invest Dermatol; 1993 Jun 22; 100(6):812-5. PubMed ID: 8496621 [Abstract] [Full Text] [Related]
14. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo. Kemp EH, Gavalas NG, Gawkrodger DJ, Weetman AP. Autoimmun Rev; 2007 Jan 22; 6(3):138-42. PubMed ID: 17289548 [Abstract] [Full Text] [Related]
15. [Autoantibodies in vitiligo]. Herz KC. Med Klin; 1978 Oct 27; 73(43):3. PubMed ID: 713958 [No Abstract] [Full Text] [Related]
16. Vitiligo and antibodies to melanocytes. Bystryn JC, Pfeffer S. Prog Clin Biol Res; 1988 Oct 27; 256():195-206. PubMed ID: 3285350 [Abstract] [Full Text] [Related]
17. Vitiligo and autoimmune polyendocrine deficiencies with autoantibodies to melanin-producing cells. Betterle C, Peserico A, Bersani G. Arch Dermatol; 1979 Mar 27; 115(3):364. PubMed ID: 581928 [No Abstract] [Full Text] [Related]
18. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Cui J, Bystryn JC. Arch Dermatol; 1995 Mar 27; 131(3):314-8. PubMed ID: 7887661 [Abstract] [Full Text] [Related]
19. Elevated serum antimelanocyte antibody level in cerebriform intradermal nevus with vitiligo. Lee CH, Yu HS. J Dermatol; 2004 Jul 27; 31(7):540-5. PubMed ID: 15492418 [Abstract] [Full Text] [Related]